Global Breast Milk Substitute Market Overview:
Breast milk substitute refers to any food that is branded or otherwise described as a partial or complete substitute for breast milk. Breast milk substitutes aim to provide the same or similar nutrition as breast milk to the infant. It is manufactured for infants and by taking into account their digestive system. There might be many reasons one might need breast milk substitutes. An increasing labor force participation of women is one of the big reasons. Other reasons may include the inability of the mother to provide milk to an infant. It might be because of health issues. Breast milk substitute is generally in form of liquid or powder which can be converted to a liquid for easy intake by an infant.
Growth Drivers
- Growing Number of Working-Class Women
- High Birth Rate in Developing Countries
Market Trends
- Huge Investments for the R&D in Breast Milk Substitutes
Roadblocks
- Stringent Regulations Hampering the Demand of Breast Milk Substitutes
Opportunities
- Increasing Education Among Women Will Be Indirectly Responsible for Growing Demand Of Breast Milk Substitutes
- Growing Demand of Breast Milk Substitutes from Developed Countries
Challenges
- Public Opinion Against Breast Milk Substitutes
- Lack of Awareness About Breast Milk Substitutes
Competitive Landscape:
Some of the key players profiled in the report are Kraft Heinz Company (United States), Fonterra Co-operative Group (New Zealand), Abbott Nutrition (United States), Nestle (Switzerland), Mead Johnson & Company (United States), Danone (France), Vitagermine SAS (United States), FrieslandCampina (Netherlands) and MDPI (Switzerland). Considering Market by Form, the sub-segment i.e. Powder will boost the Breast Milk Substitute market. Considering Market by Sales Channel, the sub-segment i.e. Online will boost the Breast Milk Substitute market. Considering Market by Product, the sub-segment i.e. Milk-based formula will boost the Breast Milk Substitute market.
In Aug 2019, Nestle performed clinical trials on 75 premature babies in five hospitals on replacements for breast milk in complete violation of the Infant Milk Substitutes Act, according to the Breastfeeding Promotion Network of India (BPNI), which screened the trial registry of the Indian Council of Medical Research (ICMR). 75 premature babies between the ages of 28 and 34 weeks took part in the study. The study's aim was to evaluate preterm infants' development and feeding intolerance.
According to the Code of WHO for breast milk substitutes; “There should be no advertising or other form of promotion to the general public of products within the scope of this Code.” And “Manufacturers and distributors should not provide, directly or indirectly, to pregnant women, mothers or members of their families, samples of products within the scope of this Code.”
What Can be Explored with the Breast Milk Substitute Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Breast Milk Substitute Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Breast Milk Substitute
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Breast Milk Substitute market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Breast Milk Substitute market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Breast Milk Substitutes Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.